Ireland’s Mr IPO and his plans to make more companies public
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Company signs strategic collaboration agreement with a Nasdaq listed biopharma company
It is expected that granting of the application will follow upon completion of formalities.
Biopharmaceutical company hails work with CytoReason as ‘significant breakthrough’
Company recently reported positive data from POLB 001 human challenge trial
Treatment is strain agnostic, and is being developed to treat acute inflammatory conditions
No further clinical activity required, bringing the recruitment and clinical phase to a close on schedule
Company has been working with OneThree Biotech to us artificial intelligence to identify novel drug targets for RSV treatment
Open Orphan spinout has applied for extra intellectual property protection for uses against other illnesses
Largest individual investor understood to be an experienced life science investor
Project could yield new and better treatments for disease
Immunotherapy could be used to treat conditions such as influenza and Covid-19
Company signs licence for MelioVac, a pre-clinical vaccine for melioidosis
Seen & heard: global tax rate above 15%; phasing out leasing of social housing; Poolbeg to seek Nasdaq listing
Ryanair the main market mover in Dublin as it rises 3% while Glanbia and AIB dip
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices